PubRank

Anastasios A Tsiatis

Author PubWeight™ 57.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008 4.33
2 Semiparametric Estimation of Treatment Effect in a Pretest-Posttest Study with Missing Data. Stat Sci 2005 3.90
3 A robust method for estimating optimal treatment regimes. Biometrics 2012 3.76
4 Median regression with censored cost data. Biometrics 2002 3.34
5 Improving efficiency of inferences in randomized clinical trials using auxiliary covariates. Biometrics 2008 3.04
6 A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data. Biometrics 2002 2.74
7 Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data. Biometrika 2009 2.61
8 Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006 2.60
9 Semiparametric estimation of treatment effect in a pretest-posttest study. Biometrics 2003 2.53
10 Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 2002 2.50
11 The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol 2004 2.34
12 Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics 2004 2.07
13 Estimating Optimal Treatment Regimes from a Classification Perspective. Stat 2012 1.95
14 Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol 2004 1.94
15 An estimator for the proportional hazards model with multiple longitudinal covariates measured with error. Biostatistics 2002 1.63
16 Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. Biometrika 2013 1.59
17 Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure. Lifetime Data Anal 2005 1.54
18 Adaptive two-stage designs in phase II clinical trials. Stat Med 2006 1.38
19 Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005 1.12
20 Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics 2013 1.09
21 On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data. Stat Methods Med Res 2012 1.09
22 Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. Stat Med 2008 0.96
23 Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored. Biometrics 2004 0.93
24 Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial. Biostatistics 2010 0.89
25 Mixed model analysis of censored longitudinal data with flexible random-effects density. Biostatistics 2011 0.87
26 Multiple imputation approaches for the analysis of dichotomized responses in longitudinal studies with missing data. Biometrics 2010 0.86
27 Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods. Circulation 2004 0.86
28 Assessing the causal effect of organ transplantation on the distribution of residual lifetime. Biometrics 2013 0.84
29 Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). Am J Cardiol 2004 0.77
30 Response to reader reaction. Biometrics 2014 0.75
31 Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed. Lifetime Data Anal 2013 0.75
32 Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring. Lifetime Data Anal 2011 0.75